Published on June 18, 2024
Exhibit 107
Calculation of Filing Fee Tables
FORM S-1
(Form Type)
FibroBiologics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
|
Security Type |
Security Class Title |
Fee Calculation Rule |
Amount Registered |
(1) |
Proposed Maximum Offering Price Per Unit |
Maximum Aggregate Offering Price |
Fee Rate |
Amount of Registration Fee |
||||||||||||||||
| Equity | Common stock, par value $0.00001 per share | Rule 457(d) | 16,022,644 | (2) | $ | 6.73 | (2) | $ | 107,832,394.12 | 147.60 per $1,000,000 | $ | 15,916.06 | ||||||||||||
| Total Offering Amounts | $ | 107,832,394.12 | $ | 15,916.06 | ||||||||||||||||||||
| Total Fee Offsets | — | |||||||||||||||||||||||
| Net Fee Due | $ | 15,916.06 | ||||||||||||||||||||||
| (1) | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended, or the Securities Act, this Registration Statement on Form S-1 shall be deemed to cover any additional shares of common stock, par value $0.00001 per share, or the Common Stock, of FibroBiologics, Inc. that may be issued as a result of any stock dividend, stock split, recapitalization or other similar transaction, and any other securities with respect to which the outstanding shares are converted or exchanged. | |
| (2) | Estimated solely for purposes of calculating the registration fee in accordance with Rule 457(d) under the Securities Act, based on a market value per share reference price of $6.73, which was the last reported sales price of our common stock on June 17, 2024. |